These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26531326)

  • 61. Butyrate, but not propionate, reverses maternal diet-induced neurocognitive deficits in offspring.
    Yu L; Zhong X; He Y; Shi Y
    Pharmacol Res; 2020 Oct; 160():105082. PubMed ID: 32679183
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aflatoxin B1 Disrupts Gut-Microbial Metabolisms of Short-Chain Fatty Acids, Long-Chain Fatty Acids, and Bile Acids in Male F344 Rats.
    Zhou J; Tang L; Wang J; Wang JS
    Toxicol Sci; 2018 Aug; 164(2):453-464. PubMed ID: 29897551
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implication of Gut Microbiota in Cardiovascular Diseases.
    Zhou W; Cheng Y; Zhu P; Nasser MI; Zhang X; Zhao M
    Oxid Med Cell Longev; 2020; 2020():5394096. PubMed ID: 33062141
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Flavones interact with fiber to affect fecal bacterial communities in vitro.
    Loo YT; Howell K; Suleria H; Zhang P; Liu S; Ng K
    Food Chem; 2023 Mar; 404(Pt B):134721. PubMed ID: 36323044
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects.
    Bouter K; Bakker GJ; Levin E; Hartstra AV; Kootte RS; Udayappan SD; Katiraei S; Bahler L; Gilijamse PW; Tremaroli V; Stahlman M; Holleman F; van Riel NAW; Verberne HJ; Romijn JA; Dallinga-Thie GM; Serlie MJ; Ackermans MT; Kemper EM; Willems van Dijk K; Backhed F; Groen AK; Nieuwdorp M
    Clin Transl Gastroenterol; 2018 May; 9(5):155. PubMed ID: 29799027
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.
    Behr C; Slopianka M; Haake V; Strauss V; Sperber S; Kamp H; Walk T; Beekmann K; Rietjens IMCM; van Ravenzwaay B
    Toxicol Appl Pharmacol; 2019 Jan; 363():79-87. PubMed ID: 30502395
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Simultaneous HS-SPME GC-MS determination of short chain fatty acids, trimethylamine and trimethylamine N-oxide for gut microbiota metabolic profile.
    Fiori J; Turroni S; Candela M; Brigidi P; Gotti R
    Talanta; 2018 Nov; 189():573-578. PubMed ID: 30086962
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome.
    Green M; Arora K; Prakash S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326175
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dietary betaine reduces liver lipid accumulation via improvement of bile acid and trimethylamine-N-oxide metabolism in blunt-snout bream.
    Wang F; Xu J; Jakovlić I; Wang WM; Zhao YH
    Food Funct; 2019 Oct; 10(10):6675-6689. PubMed ID: 31559407
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gut microbiota and microbiota-derived metabolites in cardiovascular diseases.
    Chen X; Zhang H; Ren S; Ding Y; Remex NS; Bhuiyan MS; Qu J; Tang X
    Chin Med J (Engl); 2023 Oct; 136(19):2269-2284. PubMed ID: 37442759
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Friend or foe? The roles of inulin-type fructans.
    Man S; Liu T; Yao Y; Lu Y; Ma L; Lu F
    Carbohydr Polym; 2021 Jan; 252():117155. PubMed ID: 33183606
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
    Fang Y; Zhang J; Zhu S; He M; Ma S; Jia Q; Sun Q; Song L; Wang Y; Duan L
    Pharmacol Res; 2021 Mar; 165():105439. PubMed ID: 33493658
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Li DY; Tang WHW
    Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of the microbiome for human health: from basic science to clinical applications.
    Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
    Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
    O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease.
    Zhao M; Chen S; Ji X; Shen X; You J; Liang X; Yin H; Zhao L
    Pharmacol Res; 2021 Apr; 166():105517. PubMed ID: 33636349
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling.
    Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Bäckhed F; Marschall HU
    Dig Dis; 2017; 35(3):246-250. PubMed ID: 28249261
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gut Microbiota and Atherosclerosis.
    Li DY; Tang WHW
    Curr Atheroscler Rep; 2017 Aug; 19(10):39. PubMed ID: 28842845
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Applying mass spectrometry-based assays to explore gut microbial metabolism and associations with disease.
    Heaney LM
    Clin Chem Lab Med; 2020 Apr; 58(5):719-732. PubMed ID: 31639103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.